Compare · AIT vs CLGN
AIT vs CLGN
Side-by-side comparison of Applied Industrial Technologies Inc. (AIT) and CollPlant Biotechnologies Ltd (CLGN): market cap, price performance, sector, and recent activity on the wire.
Summary
- AIT operates in Consumer Discretionary, while CLGN operates in Health Care - the two are in different parts of the market.
- AIT is the larger of the two at $12.10B, about 2295.9x CLGN ($5.3M).
- Over the past year, AIT is up 28.8% and CLGN is down 79.1% - AIT leads by 107.9 points.
- AIT has been more active in the news (5 items in the past 4 weeks vs 4 for CLGN).
- AIT has more recent analyst coverage (12 ratings vs 1 for CLGN).
- Company
- Applied Industrial Technologies Inc.
- CollPlant Biotechnologies Ltd
- Price
- $327.75-0.45%
- $0.37-13.31%
- Market cap
- $12.10B
- $5.3M
- 1M return
- +2.74%
- +1.96%
- 1Y return
- +28.81%
- -79.09%
- Industry
- Industrial Specialties
- Industrial Specialties
- Exchange
- NYSE
- NASDAQ
- IPO
- News (4w)
- 5
- 4
- Recent ratings
- 12
- 1
Applied Industrial Technologies Inc.
Applied Industrial Technologies, Inc. distributes industrial products in North America, Australia, New Zealand, and Singapore. The company offers its products for maintenance, repair, and operational, as well as original equipment manufacturing customers. It operates in two segments, Service Center Based Distribution, and Fluid Power & Flow Control. The company distributes bearings, power transmission products, engineered fluid power components and systems, specialty flow control solutions, machinery and robotics automation products, industrial rubber products, linear motion components, tools, safety products, oilfield supplies, and other industrial and maintenance supplies; and offers motors, belting, drives, couplings, pumps, hydraulic and pneumatic components, filtration supplies, valves, fittings, process instrumentation, actuators, and hoses, as well as other related supplies for general operational needs of customers' machinery and equipment. It also operates fabricated rubber shops and service field crews that install, modify, and repair conveyor belts and rubber linings, as well as offer hose assemblies. In addition, the company offers equipment repair and technical support services. It offers industrial products through a network of service centers. The company serves various industries, including agriculture and food processing, cement, chemicals and petrochemicals, fabricated metals, forest products, industrial machinery and equipment, mining, oil and gas, primary metals, transportation, and utilities, as well as to government entities. Applied Industrial Technologies, Inc. was founded in 1923 and is headquartered in Cleveland, Ohio.
CollPlant Biotechnologies Ltd
CollPlant Biotechnologies Ltd., a regenerative and aesthetic medicine company, focuses on three-dimensional (3D) bioprinting of tissues and organs, and medical aesthetics in the United States, Canada, and Europe. Its products are based on recombinant type I human collagen that is produced with its proprietary plant based genetic engineering technology. The company's products include BioInks for 3D printing of tissues and organs; dermal filler for treating wrinkles; 3D Bioprinted breast implants that are used for the regeneration of breast tissue; injectable implants to promote breast tissue regeneration; VergenixSTR, a soft tissue repair matrix intended for the treatment of tendinopathy; and VergenixFG, an advanced wound care product for the treatment of deep surgical incisions and wounds, including diabetic ulcers, venous and pressure ulcers, burns, bedsores, and other chronic wounds. It has a co-development agreement with 3D Systems Corporation for a 3D bioprinted regenerative soft tissue matrix for use in breast reconstruction procedures in combination with an implant. The company was formerly known as CollPlant Holdings Ltd. and changed its name to CollPlant Biotechnologies Ltd. in June 2019. CollPlant Biotechnologies Ltd. was founded in 2004 and is headquartered in Rehovot, Israel.
Latest AIT
- Director Wallace Peter C disposed of $191,196 worth of shares (584 units at $327.39) and acquired $191,196 worth of shares (584 units at $327.39), increasing direct ownership by 2% to 24,763 units (SEC Form 4)
- Director Wallace Peter C was granted 5 shares (SEC Form 4)
- Applied Industrial Technologies Inc. filed SEC Form 8-K: Leadership Update, Financial Statements and Exhibits
- Applied Industrial Technologies Declares Quarterly Dividend
- Director Andrews Madhuri A sold $1,268,427 worth of shares (3,845 units at $329.89), decreasing direct ownership by 44% to 4,951 units (SEC Form 4)
- SEC Form 11-K filed by Applied Industrial Technologies Inc.
- DA Davidson initiated coverage on Applied Industrial with a new price target
- SEC Form SD filed by Applied Industrial Technologies Inc.
- VP, General Mgr-Fluid Power Hoffner Warren E Iii sold $2,448,280 worth of shares (8,000 units at $306.04), decreasing direct ownership by 16% to 40,751 units (SEC Form 4)
- VP-General Counsel & Secretary Ploetz Jon S covered exercise/tax liability with 146 shares, decreasing direct ownership by 4% to 3,296 units (SEC Form 4) to satisfy withholding tax
Latest CLGN
- SEC Form F-3 filed by CollPlant Biotechnologies Ltd
- SEC Form 6-K filed by CollPlant Biotechnologies Ltd
- SEC Form 6-K filed by CollPlant Biotechnologies Ltd
- COLLPLANT BIOTECHNOLOGIES ANNOUNCES $2.6 MILLION PRIVATE PLACEMENT
- SEC Form 6-K filed by CollPlant Biotechnologies Ltd
- COLLPLANT BIOTECHNOLOGIES REPORTS 2026 FIRST QUARTER FINANCIAL RESULTS AND PROVIDES CORPORATE UPDATE
- New insider Evans Hugh M claimed ownership of 10,000 units of Restricted Share Units and claimed ownership of 340,554 units of Ordinary Shares (SEC Form 3)
- SEC Form EFFECT filed by CollPlant Biotechnologies Ltd
- SEC Form 424B3 filed by CollPlant Biotechnologies Ltd
- Amendment: SEC Form F-1/A filed by CollPlant Biotechnologies Ltd